David Bredt
Förmögenhet: 16 M $ per 2026-07-31
Förmögenhet: 16 M $ per 2026-07-31
Dr. David Bredt is a Chief Scientific Officer at Rapport Therapeutics, Inc. He is on the Board of Directors at CONNECT.
Dr. Bredt was previously employed as a Partner by MPM BioImpact LLC, a Global Head-Neuroscience Discovery by Janssen Global Services LLC, and a Vice President-Neuroscience by Eli Lilly & Co. He received his undergraduate degree from Princeton University and a doctorate degree from The Johns Hopkins University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-19 | 393 075 ( 0,82 % ) | 16 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Grundare | 2022-02-01 |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Företagsledare/Principal | 2021-08-02 |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Företagsledare/Principal | 2021-03-01 |
| ELI LILLY AND COMPANY | Företagsledare/Principal | 2011-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån